<DOC>
	<DOCNO>NCT00050518</DOCNO>
	<brief_summary>The study seek define , precision , safety efficacy APSV , two dose potency one lot vaccinia-naive adult . The ability vaccine induce classic �take� define formation lesion injection site consistent �Jennerian� process ( see Appendix A ) vaccine specific immune response assess . The local cutaneous lesion consider surrogate clinical effectiveness live , replicate smallpox vaccine . Neutralizing antibody formation correlate take Dryvax vaccine consider cross-protective orthopoxviruses , include variola . The study also seek characterize preliminarily cell mediate immune ( CMI ) response APSV ( compare Dryvax ) .</brief_summary>
	<brief_title>APSV Vaccinia Naive Adults</brief_title>
	<detailed_description>A Multicenter , double blind , randomize trial volunteer receive one 2 dose concentration one two lot Aventis Pasteur Smallpox Vaccine single vaccination ( undiluted , 1:5 dilution ) . Volunteers without take day 7 - 9 offer vaccination Dryvax end study .</detailed_description>
	<mesh_term>Vaccinia</mesh_term>
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>INCLUSION CRITERIA : Adequate renal function define serum creatinine 1.5 mg/dL ; urine protein &lt; 100mg/ dL trace negative proteinuria ( dipstick ) , calculate creatinine clearance &gt; 55 mL/min . Formula calculation contain within Manual Procedures . ( Note : Renal function measure ensure subject could meet criterion use cidofovir need ) . Age 1832 ( child exclude due concern safety , include autoinoculation ) . Willing sign inform consent . Availability followup plan duration study ( 56 day follow last vaccination ) . Acceptable medical history screen evaluation form brief assessment . Absence typical vaccinia scar negative history smallpox vaccination . Negative urine serum pregnancy test woman childbearing potential . If volunteer female childbearing potential , agree use acceptable contraception , become pregnant duration study . ( Acceptable contraception include implant , injectables , combine oral contraceptive , effective intrauterine device ( IUDs ) , sexual abstinence , vasectomized partner ) . Negative ELISA HIV negative Western blot subject positive ELISA participate HIV vaccine trial . Negative hepatitis B surface antigen negative antibody hepatitis C virus . Negative urine glucose dipstick . ALT &lt; 1.5 time institutional upper limit normal . EXCLUSION CRITERIA : Allergies component vaccine ( e.g. , polymyxin B sulfate , dihydrostreptomycin sulfate , chlorotetracycline hydrochloride ) . History immunodeficiency . Serology positive HIV , hepatitis B , hepatitis C screen visit . Known suspected impairment immunologic function include , limited clinically significant liver disease . Diabetes mellitus . Moderate severe kidney impairment . Malignancy exception squamous cell basal cell skin cancer . Autoimmune disease . Use immunosuppressive medication . Corticosteroid nasal spray permissible . Medical psychiatric condition occupational responsibility preclude subject compliance protocol . History illegal injection drug use . Live attenuate vaccine within 60 day study . Use experimental agent within 30 day prior study . Any history vaccination vaccinia vectored pox vectored experimental vaccine . Smallpox vaccination since 1990 ( Vaccinia experience cohort ) . Typical vaccinia scar history smallpox vaccination ( Vaccinia naive cohort ) . Receipt blood product immunoglobulin past 6 month . Recent donation equivalent pint blood within 30 day prior enrollment . Acute febrile illness ( 100.5 F ) day vaccination . Pregnant lactating woman . Eczema degree history eczema . History exfoliative skin disorders/conditions . Any acute skin disorder large magnitude , e.g. , laceration require suture , burn great 2x2 cm . Household contacts/sexual contact , close frequent occupational exposure , follow : pregnant woman , child &lt; 12 month age , people eczema history eczema , people skin disorders/conditions previously list , people immunodeficiency disease use immunosuppressive medication . Any condition , opinion investigator , might interfere study objective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>32 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Smallpox</keyword>
	<keyword>Aventis Pasteur</keyword>
	<keyword>Vaccine</keyword>
</DOC>